$ACOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACORDA THERAPEUTICS INC. Get notifications about new insider transactions in ACORDA THERAPEUTICS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 17 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15 2012 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Buy | M | 12.48 | 1,282 | 15,999 | 4,194 | 2.9 K to 4.2 K (+44.02 %) |
| Oct 24 2012 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Option Exercise | M | 2.60 | 9,481 | 24,651 | 19,296 | |
| Oct 24 2012 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Sell | S | 23.08 | 9,481 | 218,821 | 68,525 | 78 K to 68.5 K (-12.15 %) |
| Oct 24 2012 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Buy | M | 2.60 | 9,481 | 24,651 | 78,006 | 68.5 K to 78 K (+13.84 %) |
| Oct 18 2012 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Sell | S | 23.55 | 3,100 | 73,005 | 30,000 | 33.1 K to 30 K (-9.37 %) |
| Oct 05 2012 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Chief, St. Dev. and ... | Option Exercise | A | 26.46 | 50,000 | 1,323,000 | 50,000 | |
| Oct 05 2012 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Chief, St. Dev. and ... | Grant | A | 0.00 | 30,000 | 0 | 104,970 | 75 K to 105 K (+40.02 %) |
| Jun 07 2012 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 22.44 | 10,000 | 224,400 | 10,000 | |
| Jun 07 2012 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 22.44 | 10,000 | 224,400 | 10,000 | |
| Jun 07 2012 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 22.44 | 10,000 | 224,400 | 10,000 | |
| Jun 07 2012 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 22.44 | 10,000 | 224,400 | 10,000 | |
| Jun 07 2012 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 22.44 | 10,000 | 224,400 | 10,000 | |
| Jun 07 2012 | ACOR | ACORDA THERAPEUTIC ... | Jensen Peder | Director | Option Exercise | A | 22.44 | 10,000 | 224,400 | 10,000 | |
| Jun 07 2012 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | A | 22.44 | 10,000 | 224,400 | 10,000 | |
| Apr 20 2012 | ACOR | ACORDA THERAPEUTIC ... | Jensen Peder | Director | Option Exercise | A | 24.31 | 1,372 | 33,353 | 1,372 | |
| Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Chief, St. Dev. and ... | Option Exercise | A | 26.35 | 52,200 | 1,375,470 | 52,200 | |
| Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Chief, St. Dev. and ... | Grant | A | 0.00 | 17,400 | 0 | 74,970 | 57.6 K to 75 K (+30.22 %) |
| Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Exec. VP-Commercial ... | Option Exercise | A | 26.35 | 27,000 | 711,450 | 27,000 | |
| Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Exec. VP-Commercial ... | Grant | A | 0.00 | 9,000 | 0 | 36,016 | 27 K to 36 K (+33.31 %) |
| Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | A | 26.35 | 33,000 | 869,550 | 33,000 | |
| Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Grant | A | 0.00 | 11,000 | 0 | 27,249 | 16.2 K to 27.2 K (+67.70 %) |
| Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 26.35 | 112,500 | 2,964,375 | 112,500 | |
| Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 37,500 | 0 | 342,997 | 305.5 K to 343 K (+12.28 %) |
| Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Option Exercise | A | 26.35 | 24,300 | 640,305 | 24,300 | |
| Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Grant | A | 0.00 | 8,100 | 0 | 33,100 | 25 K to 33.1 K (+32.40 %) |
| Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Option Exercise | A | 26.35 | 41,400 | 1,090,890 | 41,400 | |
| Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Grant | A | 0.00 | 13,800 | 0 | 68,525 | 54.7 K to 68.5 K (+25.22 %) |
| Dec 23 2011 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | M | 23.40 | 1,282 | 29,999 | 0 | |
| Dec 23 2011 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Grant | A | 23.40 | 1,282 | 29,999 | 2,912 | 1.6 K to 2.9 K (+78.65 %) |
| Dec 05 2011 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Exec. VP-Commercial ... | Sell | S | 22.91 | 4,364 | 99,979 | 27,016 | 31.4 K to 27 K (-13.91 %) |
| Dec 05 2011 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.92 | 7,344 | 168,324 | 57,570 | 64.9 K to 57.6 K (-11.31 %) |
| Dec 05 2011 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 22.92 | 9,896 | 226,816 | 16,249 | 26.1 K to 16.2 K (-37.85 %) |
| Dec 05 2011 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 22.92 | 16,500 | 378,180 | 305,497 | 322 K to 305.5 K (-5.12 %) |
| Dec 05 2011 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Sell | S | 22.92 | 7,000 | 160,440 | 54,725 | 61.7 K to 54.7 K (-11.34 %) |
| Sep 16 2011 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Option Exercise | A | 23.04 | 10,000 | 230,400 | 10,000 | |
| Jun 20 2011 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 31.25 | 10,000 | 312,500 | 10,000 | |
| Jun 20 2011 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 31.25 | 10,000 | 312,500 | 10,000 | |
| Jun 20 2011 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 31.25 | 10,000 | 312,500 | 10,000 | |
| Jun 09 2011 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 30.87 | 12,000 | 370,440 | 321,997 | 334 K to 322 K (-3.59 %) |
| Jun 20 2011 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 31.25 | 10,000 | 312,500 | 10,000 | |
| Jun 20 2011 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 31.25 | 10,000 | 312,500 | 10,000 | |
| Jun 20 2011 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | A | 31.25 | 10,000 | 312,500 | 10,000 | |
| May 31 2011 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 60,000 | 156,000 | 251,317 | |
| May 31 2011 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 32.58 | 60,000 | 1,954,800 | 333,997 | 394 K to 334 K (-15.23 %) |
| May 31 2011 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 60,000 | 156,000 | 393,997 | 334 K to 394 K (+17.96 %) |
| May 23 2011 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | M | 6.00 | 2,500 | 15,000 | 10,198 | |
| May 23 2011 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Sell | S | 31.60 | 2,500 | 79,000 | 0 | 2.5 K to 0 (-100.00 %) |
| May 23 2011 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Buy | M | 6.00 | 2,500 | 15,000 | 2,500 | 0 to 2.5 K |
| Apr 21 2011 | ACOR | ACORDA THERAPEUTIC ... | Jensen Peder | Director | Option Exercise | A | 27.99 | 25,000 | 699,750 | 25,000 | |
| Apr 19 2011 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 60,000 | 156,000 | 311,317 | |
| Apr 19 2011 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 28.24 | 60,000 | 1,694,400 | 333,997 | 394 K to 334 K (-15.23 %) |
| Apr 19 2011 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 60,000 | 156,000 | 393,997 | 334 K to 394 K (+17.96 %) |
| Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 22.06 | 131,250 | 2,895,375 | 131,250 | |
| Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 43,750 | 0 | 333,997 | 290.2 K to 334 K (+15.07 %) |
| Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | Wessel Thomas | Chief Medical Offic ... | Option Exercise | A | 22.06 | 26,250 | 579,075 | 26,250 | |
| Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | Wessel Thomas | Chief Medical Offic ... | Grant | A | 0.00 | 8,750 | 0 | 36,350 | 27.6 K to 36.4 K (+31.70 %) |
| Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Option Exercise | A | 22.06 | 56,250 | 1,240,875 | 56,250 | |
| Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Grant | A | 0.00 | 18,750 | 0 | 64,914 | 46.2 K to 64.9 K (+40.62 %) |
| Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Exec. VP-Commercial ... | Option Exercise | A | 22.06 | 30,938 | 682,492 | 30,938 | |
| Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Exec. VP-Commercial ... | Grant | A | 0.00 | 10,313 | 0 | 31,380 | 21.1 K to 31.4 K (+48.95 %) |
| Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | A | 22.06 | 37,500 | 827,250 | 37,500 | |
| Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Grant | A | 0.00 | 12,500 | 0 | 26,145 | 13.6 K to 26.1 K (+91.61 %) |
| Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Option Exercise | A | 22.06 | 45,000 | 992,700 | 45,000 | |
| Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Grant | A | 0.00 | 15,000 | 0 | 61,725 | 46.7 K to 61.7 K (+32.10 %) |
| Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 22.28 | 19,867 | 442,637 | 0 | 19.9 K to 0 (-100.00 %) |
| Mar 03 2011 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 21.00 | 109,188 | 2,292,948 | 19,867 | 129.1 K to 19.9 K (-84.61 %) |
| Jan 11 2011 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | M | 6.00 | 5,000 | 30,000 | 12,698 | |
| Jan 11 2011 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Sell | S | 30.00 | 5,000 | 150,000 | 0 | 5 K to 0 (-100.00 %) |
| Jan 11 2011 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Buy | M | 6.00 | 5,000 | 30,000 | 5,000 | 0 to 5 K |
| Dec 03 2010 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 26.38 | 4,900 | 129,262 | 46,164 | 51.1 K to 46.2 K (-9.60 %) |
| Dec 03 2010 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 26.82 | 2,600 | 69,732 | 51,064 | 53.7 K to 51.1 K (-4.84 %) |
| Dec 03 2010 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Exec. VP-Commercial ... | Sell | S | 26.53 | 3,933 | 104,342 | 21,067 | 25 K to 21.1 K (-15.73 %) |
| Dec 03 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 26.39 | 7,405 | 195,418 | 13,645 | 21.1 K to 13.6 K (-35.18 %) |
| Dec 03 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 26.85 | 3,500 | 93,975 | 21,050 | 24.6 K to 21.1 K (-14.26 %) |
| Dec 03 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 26.40 | 10,900 | 287,760 | 290,247 | 301.1 K to 290.2 K (-3.62 %) |
| Dec 03 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 26.89 | 4,100 | 110,249 | 301,147 | 305.2 K to 301.1 K (-1.34 %) |
| Dec 03 2010 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Payment of Exercise | F | 26.47 | 5,383 | 142,488 | 46,725 | 52.1 K to 46.7 K (-10.33 %) |
| Aug 24 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 1,602 | 4,165 | 0 | |
| Aug 24 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 17,094 | 44,444 | 0 | |
| Aug 24 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 1,602 | 4,165 | 305,247 | 303.6 K to 305.2 K (+0.53 %) |
| Aug 24 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 17,094 | 44,444 | 303,645 | 286.6 K to 303.6 K (+5.97 %) |
| Aug 12 2010 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | M | 6.00 | 5,000 | 30,000 | 17,698 | |
| Aug 12 2010 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Sell | S | 33.52 | 5,000 | 167,600 | 0 | 5 K to 0 (-100.00 %) |
| Aug 12 2010 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Buy | M | 6.00 | 5,000 | 30,000 | 5,000 | 0 to 5 K |
| Aug 10 2010 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 35.02 | 15,000 | 525,300 | 129,055 | 144.1 K to 129.1 K (-10.41 %) |
| Aug 09 2010 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 35.03 | 3,280 | 114,898 | 144,055 | 147.3 K to 144.1 K (-2.23 %) |
| Aug 09 2010 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 36.20 | 35,864 | 1,298,277 | 147,335 | 183.2 K to 147.3 K (-19.58 %) |
| Aug 09 2010 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 35.86 | 160,856 | 5,768,296 | 183,199 | 344.1 K to 183.2 K (-46.75 %) |
| Aug 09 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 55,000 | 143,000 | 371,317 | |
| Aug 09 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 36.51 | 6,783 | 247,647 | 286,551 | 293.3 K to 286.6 K (-2.31 %) |
| Aug 09 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 35.85 | 48,217 | 1,728,579 | 293,334 | 341.6 K to 293.3 K (-14.12 %) |
| Aug 09 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 55,000 | 143,000 | 341,551 | 286.6 K to 341.6 K (+19.19 %) |
| Aug 09 2010 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | M | 8.14 | 30,000 | 244,200 | 2,698 | |
| Aug 09 2010 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Sell | S | 36.21 | 30,000 | 1,086,300 | 0 | 30 K to 0 (-100.00 %) |
| Aug 09 2010 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Buy | M | 8.14 | 30,000 | 244,200 | 30,000 | 0 to 30 K |
| Jun 16 2010 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 34.00 | 8,397 | 285,498 | 344,055 | 352.5 K to 344.1 K (-2.38 %) |
| Jun 14 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 31.61 | 133,333 | 4,214,656 | 133,333 | |
| Jun 14 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 66,667 | 0 | 286,551 | 219.9 K to 286.6 K (+30.32 %) |
| Jun 10 2010 | ACOR | ACORDA THERAPEUTIC ... | YOUNG WISE | Director | Option Exercise | A | 31.61 | 10,000 | 316,100 | 10,000 | |
| Jun 10 2010 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 31.61 | 10,000 | 316,100 | 10,000 | |
| Jun 10 2010 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 31.61 | 10,000 | 316,100 | 10,000 | |
| Jun 10 2010 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 31.61 | 10,000 | 316,100 | 10,000 | |
| Jun 10 2010 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 31.61 | 10,000 | 316,100 | 10,000 | |
| Jun 10 2010 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | A | 31.61 | 10,000 | 316,100 | 10,000 | |
| Jun 10 2010 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 31.61 | 10,000 | 316,100 | 10,000 | |
| Apr 02 2010 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Option Exercise | A | 34.20 | 40,000 | 1,368,000 | 40,000 | |
| Apr 02 2010 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Grant | A | 0.00 | 20,000 | 0 | 53,664 | 33.7 K to 53.7 K (+59.41 %) |
| Apr 02 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | A | 34.20 | 27,500 | 940,500 | 27,500 | |
| Apr 02 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Grant | A | 0.00 | 13,750 | 0 | 24,550 | 10.8 K to 24.6 K (+127.31 %) |
| Apr 02 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 34.20 | 100,000 | 3,420,000 | 100,000 | |
| Apr 02 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 50,000 | 0 | 219,884 | 169.9 K to 219.9 K (+29.43 %) |
| Apr 02 2010 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Option Exercise | A | 34.20 | 40,000 | 1,368,000 | 40,000 | |
| Apr 02 2010 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Grant | A | 0.00 | 20,000 | 0 | 52,108 | 32.1 K to 52.1 K (+62.29 %) |
| Mar 12 2010 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 35.01 | 8,394 | 293,913 | 352,452 | 360.8 K to 352.5 K (-2.33 %) |
| Mar 12 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 8.14 | 12,000 | 97,680 | 27,109 | |
| Mar 12 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 34.16 | 12,000 | 409,961 | 10,800 | 22.8 K to 10.8 K (-52.63 %) |
| Mar 12 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 8.14 | 12,000 | 97,680 | 22,800 | 10.8 K to 22.8 K (+111.11 %) |
| Mar 10 2010 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 34.00 | 60,000 | 2,040,048 | 360,846 | 420.8 K to 360.8 K (-14.26 %) |
| Mar 10 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 19,000 | 49,400 | 426,317 | |
| Mar 10 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 19,000 | 49,400 | 445,317 | |
| Mar 10 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 33.73 | 19,000 | 640,781 | 169,884 | 188.9 K to 169.9 K (-10.06 %) |
| Mar 10 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 19,000 | 49,400 | 188,884 | 169.9 K to 188.9 K (+11.18 %) |
| Mar 10 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 33.15 | 19,000 | 629,854 | 169,884 | 188.9 K to 169.9 K (-10.06 %) |
| Mar 10 2010 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 19,000 | 49,400 | 188,884 | 169.9 K to 188.9 K (+11.18 %) |
| Feb 03 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 8.14 | 5,000 | 40,700 | 39,109 | |
| Feb 03 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 30.00 | 5,000 | 150,000 | 10,800 | 15.8 K to 10.8 K (-31.65 %) |
| Feb 03 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 8.14 | 5,000 | 40,700 | 15,800 | 10.8 K to 15.8 K (+46.30 %) |
| Mar 03 2010 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Sell | S | 32.21 | 4,173 | 134,407 | 32,108 | 36.3 K to 32.1 K (-11.50 %) |
| Jan 26 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 8.14 | 5,000 | 40,700 | 44,109 | |
| Jan 26 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 28.00 | 5,000 | 140,000 | 10,800 | 15.8 K to 10.8 K (-31.65 %) |
| Jan 26 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 8.14 | 5,000 | 40,700 | 15,800 | 10.8 K to 15.8 K (+46.30 %) |
| Feb 03 2010 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Sell | S | 30.00 | 4,534 | 136,020 | 36,281 | 40.8 K to 36.3 K (-11.11 %) |
| Dec 17 2009 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 8.14 | 5,000 | 40,700 | 49,109 | |
| Dec 17 2009 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 24.48 | 5,000 | 122,420 | 10,800 | 15.8 K to 10.8 K (-31.65 %) |
| Dec 17 2009 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 8.14 | 5,000 | 40,700 | 15,800 | 10.8 K to 15.8 K (+46.30 %) |
| Dec 03 2009 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 24.51 | 8,500 | 208,294 | 169,884 | 178.4 K to 169.9 K (-4.77 %) |
| Dec 02 2009 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 24.50 | 5,000 | 122,507 | 33,664 | 38.7 K to 33.7 K (-12.93 %) |
| Dec 02 2009 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 24.51 | 7,466 | 182,964 | 10,800 | 18.3 K to 10.8 K (-40.87 %) |
| Dec 02 2009 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Sell | S | 24.51 | 4,500 | 110,275 | 40,815 | 45.3 K to 40.8 K (-9.93 %) |
| Aug 13 2009 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | M | 6.00 | 10,000 | 60,000 | 22,698 | |
| Aug 13 2009 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Sell | S | 23.58 | 10,000 | 235,800 | 0 | 10 K to 0 (-100.00 %) |
| Aug 13 2009 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Buy | M | 6.00 | 10,000 | 60,000 | 10,000 | 0 to 10 K |
| Jun 23 2009 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 25.45 | 10,000 | 254,500 | 10,000 | |
| Jun 23 2009 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 25.45 | 10,000 | 254,500 | 10,000 | |
| Jun 23 2009 | ACOR | ACORDA THERAPEUTIC ... | YOUNG WISE | Director | Option Exercise | A | 25.45 | 10,000 | 254,500 | 10,000 | |
| Jun 23 2009 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 25.45 | 10,000 | 254,500 | 10,000 | |
| Jun 23 2009 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 25.45 | 10,000 | 254,500 | 10,000 | |
| Jun 23 2009 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 25.45 | 10,000 | 254,500 | 10,000 | |
| Jun 23 2009 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 25.45 | 10,000 | 254,500 | 10,000 | |
| Jun 23 2009 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | A | 25.45 | 10,000 | 254,500 | 10,000 |